Miguel Ángel Ma Calleja-Hernández

8PUBLICATIONS
33CO-AUTHORS
Cancer diagnosisClinical pharmacology and therapeuticsHealth economicsCancer therapy (excl. chemotherapy and radiation therapy)Neonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 12, 2026
An Innovative Patient Stratification Tool Integrating Clinical and Economic Data for Benchmarking Oncology and Hematology Care: The PATONCOS System.

|Jan 12, 2024
A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries.

Néboa Zozaya, Javier Villaseca, Irene Fernández

|Jul 29, 2022
Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain.

Miguel Ángel Calleja, Andrés Navarro, José María Serratosa

|Jan 08, 2022
A strategic reflection for the management and implementation of CAR-T therapy in Spain: an expert consensus paper.

N Zozaya, J Villaseca, F Abdalla

|Jan 05, 2022
Adverse events reported after administration of BNT162b2 and mRNA-1273 COVID-19 vaccines among hospital workers: a cross-sectional survey-based study in a Spanish hospital.

Marta M Valera-Rubio, María Isabel Mi Sierra-Torres, Raquel R Castillejo García

|Jan 05, 2022
Effectiveness and safety of topical 15% resorcinol in the management of mild-to-moderate hidradenitis suppurativa: A cohort study.

Jaime Cordero-Ramos, Rubén Barros-Tornay, Tomás Toledo-Pastrana

Pageof 2

Frequent Collaborators

2 joint publications

Néboa Zozaya

2 joint publications

Javier Villaseca

2 joint publications

Fernando Abdalla

2 joint publications

Álvaro Hidalgo-Vega